Reducing the risk for catheter-related infections: a new strategy.
Pearson
M L
ML
Abrutyn
E
E
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D017410:Practice Guidelines as Topic; D012107:Research Design; D012306:Risk; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local